M&T Bank Corp Sells 147,548 Shares of Gilead Sciences, Inc. $GILD

M&T Bank Corp significantly reduced its stake in Gilead Sciences, Inc. (NASDAQ:GILD) by selling 147,548 shares in the fourth quarter, leaving them with 23,088 shares valued at $2.834 million. Despite this, other institutional investors increased their holdings, and analysts maintain a “Moderate Buy” rating for Gilead, with an average target price of $157.35. The biopharmaceutical company recently increased its quarterly dividend and reported strong earnings, exceeding analyst estimates in its latest quarter.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pin